
Cutera CUTR
Quarterly report 2024-Q3
added 11-12-2024
Cutera EV - Enterprise Value 2011-2026 | CUTR
Annual EV - Enterprise Value Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 421 M | 832 M | 746 M | 618 M | 451 M | 219 M | 720 M | 260 M | 174 M | 208 M | 147 M | 152 M | 114 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 832 M | 114 M | 389 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
3.89 B | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
295 M | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
170 M | $ 25.6 | -0.43 % | $ 216 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
139 M | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
1.78 B | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
4.58 B | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
340 M | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.61 | 0.36 % | $ 38 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.03 | - | $ 17.4 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
579 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
765 M | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
9.34 M | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
12.7 B | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
4.8 B | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
3.4 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
2.57 B | $ 36.8 | 0.38 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
4.62 B | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Stryker Corporation
SYK
|
21.4 B | $ 294.73 | -6.47 % | $ 113 B | ||
|
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
1.9 B | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
142 M | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
699 M | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
47 M | $ 0.9 | 4.16 % | $ 37.7 M |